83. Addison disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 20 / Drugs : 39 - (DrugBank : 13) / Drug target genes : 6 - Drug target pathways : 18
Addison disease and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 83 | Addison disease |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 46 | Malignant rheumatoid arthritis |
| 49 | Systemic lupus erythematosus |
| 53 | Sjogren syndrome |
| 113 | Muscular dystrophy |
| 65 | Primary immunodeficiency |
| 86 | Pulmonary arterial hypertension |
| 96 | Crohn disease |
| 2 | Amyotrophic lateral sclerosis |
| 64 | Thrombotic thrombocytopenic purpura |
| 285 | Fanconi anemia |
| 60 | Aplastic anemia |
| 63 | Idiopathic thrombocytopenic purpura |
| 76 | Pituitary gonadotropin secretion hyperthyroidism |
| 81 | Congenital adrenal hyperplasia |
| 14 | Chronic inflammatory demyelinating polyneuropathy |
| 74 | Prolactin secreting pituitary adenoma |
| 66 | IgA nephropathy |
| 78 | Hypopituitarism |
| 50 | Dermatomyositis |
| 222 | Primary nephrotic syndrome |
| 226 | Interstitial cystitis with Hunners ulcer |
| 84 | Sarcoidosis |
| 299 | Cystic fibrosis |
| 85 | Idiopathic interstitial pneumonia |
| 211 | Hypoplastic left heart syndrome |
| 52 | Mixed connective tissue disease |
| 220 | Rapidly progressive glomerulonephritis |
| 30 | Distal myopathy |